These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1538938)

  • 21. [Antiblastic chemotherapy in esophageal cancer].
    Cartei G
    Radiol Med; 1983; 69(7-8):597-600. PubMed ID: 6322245
    [No Abstract]   [Full Text] [Related]  

  • 22. Pilot study of intraoperative chemotherapy with cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the head and neck.
    Tulunay OE; Enamorado II; Kucuk O; Heilbrun LK; Otero JE; Korkmaz H; Blumberg R; Jacobs JR
    Head Neck; 2007 Mar; 29(3):267-71. PubMed ID: 17163471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combined chemotherapy in esophageal carcinoma-the effect of PF (A) P therapy (peplomycin, 5-fluorouracil, (adriamycin), cisplatin)].
    Toda H; Tsujinaka T; Kido Y; Ogawa M; Shiozaki H; Miyamoto T; Kambayashi J; Murata A; Kobayashi K; Nishiyama K
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):855-8. PubMed ID: 2469397
    [No Abstract]   [Full Text] [Related]  

  • 24. Multimodality treatment in the management of esophageal cancer: neoadjuvant chemoradiotherapy followed by transhiatal esophagectomy.
    Irwin JF; Waterfield W; Poussin-Rosillo H; Sardi A
    Md Med J; 1997 Oct; 46(9):471-76. PubMed ID: 9327648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multimodal therapy for esophageal adenocarcinoma.
    Badwe RA; Vaidya JS; Bhansali MS
    N Engl J Med; 1997 Jan; 336(5):374-5; author reply 375-6. PubMed ID: 9011794
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical potential of synchronous radiotherapy and chemotherapy for advanced squamous cell carcinoma.
    John MJ; Flam MS; Mowry PA
    NCI Monogr; 1988; (6):375-8. PubMed ID: 3352787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cancer of the esophagus: hopes in neo-adjuvant treatments].
    Michel P
    Gastroenterol Clin Biol; 1994; 18(4):393-4. PubMed ID: 7958665
    [No Abstract]   [Full Text] [Related]  

  • 28. [Exclusive medical management for curative treatment of squamous cell carcinoma of the esophagus: radiotherapy, chemoradiotherapy].
    Mornex F; Calais G
    Gastroenterol Clin Biol; 1999 May; 23(5):513-8. PubMed ID: 10429855
    [No Abstract]   [Full Text] [Related]  

  • 29. Phase II trial of neoadjuvant cisplatin, 5-fluorouracil and interferon-alpha in operable squamous cell carcinoma of the esophagus.
    Bazarbashi S; Abdelsalam M; Amin T; El-Bassiouni M; Soudy H; Elweshi A; Alhusseiny H; Rehman K; Memon M; Ajarim D
    Chemotherapy; 2008; 54(4):315-22. PubMed ID: 18701820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Esophageal carcinoma: current status of the therapy].
    Lopez M
    Clin Ter; 1984 Nov; 111(3):271-7. PubMed ID: 6083841
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of epidermoid cancer of the esophagus].
    Elias D; Lasser P; Eschwege F; Zummer K; Nitenberg G; Leclercq B; Kac J; Rougier P
    Ann Chir; 1984 Apr; 38(3):234-45. PubMed ID: 6375535
    [No Abstract]   [Full Text] [Related]  

  • 32. Mitotic checkpoint genes, hsMAD2 and BubR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy.
    Tanaka K; Mohri Y; Ohi M; Yokoe T; Koike Y; Morimoto Y; Miki C; Tonouchi H; Kusunoki M
    Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):639-46. PubMed ID: 18691855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma.
    Iizuka N; Hirose K; Noma T; Hazama S; Tangoku A; Hayashi H; Abe T; Yamamoto K; Oka M
    Br J Cancer; 1999 Oct; 81(3):469-75. PubMed ID: 10507772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The palliation of esophageal cancer.
    Mannell A
    Surg Annu; 1985; 17():249-70. PubMed ID: 2579448
    [No Abstract]   [Full Text] [Related]  

  • 35. Squamous cell carcinoma of the esophagus: multimodal therapy in locally advanced disease.
    El Nakadi I; Van Laethem JL; Houben JJ; Gay F; Closset J; Van Houtte P; Danhier S; Limbosch JM; Lambilliotte JP; Gelin M
    World J Surg; 2002 Jan; 26(1):72-8. PubMed ID: 11898037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Should a complementary treatment be added to surgical treatment in cancer of the esophagus? What should be the therapeutic sequence?].
    Hay JM; Maillard JN
    Rev Prat; 1989 Nov; 39(27):2437-9. PubMed ID: 2602868
    [No Abstract]   [Full Text] [Related]  

  • 37. [A case of advanced esophageal cancer resected curatively by preoperative chemotherapy with cisplatin].
    Ohyama S; Noto H; Fujita H; Miyazaki I
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2861-3. PubMed ID: 3753030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic metastasis from esophageal cancer treated by surgical resection and hepatic arterial infusion chemotherapy.
    Hanazaki K; Kuroda T; Wakabayashi M; Sodeyama H; Yokoyama S; Kusama J
    Hepatogastroenterology; 1998; 45(19):201-5. PubMed ID: 9496513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High orotate phosphoribosyltransferase gene expression predicts complete response to chemoradiotherapy in patients with squamous cell carcinoma of the esophagus.
    Kajiwara T; Nishina T; Hyodo I; Moriwaki T; Endo S; Nasu J; Hori S; Matsuura B; Hiasa Y; Onji M
    Oncology; 2009; 76(5):342-9. PubMed ID: 19307741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Epidermoid cancer of the esophagus: role of radiotherapy and chemotherapy].
    Delouche D; Haefliger JM
    Rev Med Suisse Romande; 1998 Mar; 118(3):227-34. PubMed ID: 9594596
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.